erlotinib hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ERLOTINIB SANDOZ erlotinib 25 mg tablet blister pack
AUST R: 326623
Active ingredients:
erlotinib hydrochloride

Dosage form:
Tablet, film coated

Sponsor:
Sandoz Pty Ltd

Phone:
1800726369

From
25 Jul 2025
to
12 Sep 2025

Shortage status:
Anticipated

Availability:
Available

Reason:
Unexpected increase in consumer demand

Management action:
The sponsor is working to expedite the next shipment.